Clinical Trials and Tribulations in the COVID-19 Era

Advances in treating and preventing Alzheimer disease and other neurocognitive disorders of aging arise from rigorous preclinical and clinical research, with randomized controlled treatment trials as the last and definitive test. The COVID-19 pandemic has greatly disrupted ongoing interventional stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Weinberg, Marc Scott, Patrick, Regan E., Schwab, Nadine A., Owoyemi, Praise, May, Rose, McManus, Alison J., Gerber, Jessica, Harper, David G., Arnold, Steven E., Forester, Brent
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Geriatric Psychiatry. Published by Elsevier Inc. 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236727/
https://www.ncbi.nlm.nih.gov/pubmed/32507686
http://dx.doi.org/10.1016/j.jagp.2020.05.016

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7236727/
https://www.ncbi.nlm.nih.gov/pubmed/32507686
http://dx.doi.org/10.1016/j.jagp.2020.05.016

Ejemplares similares